Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Antiepileptic drugs as prophylaxis for de novo brain tumour-related epilepsy after craniotomy: a systematic review and meta-analysis of harm and benefits

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Idiopathic intracranial hypertension: consensus guidelines on management

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Limb girdle muscular dystrophy due to mutations in POMT2

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. MRI in sarcoglycanopathies: a large international cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A snapshot of European neurosurgery December 2019 vs. March 2020: just before and during the Covid-19 pandemic

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Transcutaneous Vagus Nerve Stimulation in Patients With Severe Traumatic Brain Injury: A Feasibility Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Clinical and histopathological predictors of outcome in malignant meningioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVES: To investigate potential harm and benefits of antiepileptic drugs (AED) given prophylactically to prevent de novo brain tumour-related epilepsy after craniotomy.

METHODS: Randomised controlled trials (RCT) and retrospective studies published before 27 November 2018 were included. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were applied. Eligible patients were diagnosed with a brain tumour, were seizure naïve and underwent craniotomy. The random effects model was used for quantitative synthesis. The analysis was adjusted for the confounding effect of including patients with a history of seizure prior to study inclusion.

RESULTS: A total of 454 patients received prophylactic AED whereas 333 were allocated to placebo or no treatment. Two RCTs and four retrospective studies were identified. The OR was 1.09 (95% CI 0.7 to 1.8, p=0.7, I2=5.6%, χ2 p=0.5), indicating study consistency and no significant differences. An additional two RCTs and one retrospective study combined craniotomy and diagnostic biopsy, and were subgroup analysed-which supported no difference in odds for epilepsy.

CONCLUSIONS: A prophylactic effect of AED could not be demonstrated (nor rejected statistically). Levetiracetam was associated with less adverse effects than phenytoin. The potential harm of AED was not balanced by the potential prophylactic benefit. This study suggests that prophylactic AED should not be administered to prevent brain tumour-related epilepsy after craniotomy.

OriginalsprogEngelsk
TidsskriftJournal of neurology, neurosurgery, and psychiatry
Vol/bind90
Udgave nummer5
Sider (fra-til)599-607
Antal sider9
ISSN0022-3050
DOI
StatusUdgivet - maj 2019

Bibliografisk note

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

ID: 58216832